SPX3,647.29-7.75 -0.21%
DIA291.30-1.42 -0.49%
IXIC10,829.50+26.58 0.25%

Morgan Stanley Adjusts Accolade's Price Target to $12 from $9, Keeps Equalweight Rating

Morgan Stanley Adjusts Accolade's Price Target to $12 from $9, Keeps Equalweight Rating

MT Newswires · 09/14/2022 06:18

Please log in to view news